2023-07-01 2024-06-30 false No description of principal activity Capium Accounts Production 1.1 04023142 bus:FullAccounts 2023-07-01 2024-06-30 04023142 bus:Micro-entities 2023-07-01 2024-06-30 04023142 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 04023142 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 04023142 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 04023142 2023-07-01 2024-06-30 04023142 2024-06-30 04023142 bus:RegisteredOffice 2023-07-01 2024-06-30 04023142 core:WithinOneYear 2024-06-30 04023142 core:AfterOneYear 2024-06-30 04023142 bus:Director1 2023-07-01 2024-06-30 04023142 bus:Director1 2024-06-30 04023142 bus:Director1 2022-07-01 2023-06-30 04023142 bus:Director2 2023-07-01 2024-06-30 04023142 bus:Director2 2024-06-30 04023142 bus:Director2 2022-07-01 2023-06-30 04023142 2022-07-01 04023142 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 04023142 2022-07-01 2023-06-30 04023142 2023-06-30 04023142 core:WithinOneYear 2023-06-30 04023142 core:AfterOneYear 2023-06-30 04023142 bus:EntityAccountantsOrAuditors 2022-07-01 2023-06-30 04023142 core:PlantMachinery 2023-07-01 2024-06-30 04023142 core:PlantMachinery 2024-06-30 04023142 core:PlantMachinery 2023-06-30 04023142 core:MotorCars 2023-07-01 2024-06-30 04023142 core:MotorCars 2024-06-30 04023142 core:MotorCars 2023-06-30 04023142 core:FurnitureFittings 2023-07-01 2024-06-30 04023142 core:FurnitureFittings 2024-06-30 04023142 core:FurnitureFittings 2023-06-30 04023142 core:ComputerEquipment 2023-07-01 2024-06-30 04023142 core:ComputerEquipment 2024-06-30 04023142 core:ComputerEquipment 2023-06-30 04023142 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-06-30 04023142 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 04023142 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 04023142 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 04023142 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-06-30 04023142 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 04023142 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 04023142 core:Non-currentFinancialInstruments 2024-06-30 04023142 core:Non-currentFinancialInstruments 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 04023142
England and Wales

 

 

 

BIOPHARM TECHNICAL SOLUTIONS LIMITED


Unaudited Financial Statements
 


Period of accounts

Start date: 01 July 2023

End date: 30 June 2024
Directors Paula Smith
Philip Smith
Registered Number 04023142
Registered Office 12 Masefield Crescent
Abingdon
Oxon
OX14 5PH
Accountants Cypher
Monkswell
Little Baldon
Oxford
OX44 9PU
1
  2024   2023
    £ £   £ £
Fixed assets   9,044      11,676 
Current assets 273,783      318,866   
Prepayments and accrued income 3,360      1,730   
Creditors: amount falling due within one year (33,759)     (34,674)  
Net current assets   243,384      285,922 
Total assets less current liabilities   252,428      297,598 
Provisions for liabilities   (825)     (250)
Accruals and deferred income   (36,180)     (30,375)
Net assets   215,423      266,973 
 

         
Capital and reserves   215,423      266,973 
 
NOTES TO THE ACCOUNTS

General Information
Biopharm Technical Solutions Limited is a private company, limited by shares, registered in England and Wales, registration number 04023142, registration address 12 Masefield Crescent, Abingdon, Oxon, OX14 5PH.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees


Average number of employees during the year was 4 (2023 : 4).


For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 07 November 2024 and were signed on its behalf by:


--------------------------------
Paula Smith
Director
2